# Terumo agrees to acquire certain assets from St. Jude Medical and Abbott for $1.12 billion

Terumo Corporation reached an agreement to acquire St. Jude Medical's Angio-Seal and FemoSeal vascular closure products and Abbott's Vado steerable sheath business (via Kalila Medical) for $1.12 billion.

- Type: Acquisition
- Announced: 2016-12-07
- Where: Miami, Florida, United States
- Value: $1.12B
- Status: announced
- Products: Angio-Seal, FemoSeal vascular closure products, Vado steerable sheath
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md) (acquirer)
- [Abbott](https://endata.com/companies/4479.md) (target)
- [St. Jude Medical](https://endata.com/companies/20172.md) (target)
- [Kalila Medical](https://endata.com/companies/20531.md) (target)
- [Bolton Medical](https://endata.com/companies/21556.md) (target)

## Sources

- [evtoday.com](https://evtoday.com/news/terumo-signs-agreement-to-acquire-certain-assets-of-st-jude-medical-and-abbott), 2016-12-08: "Terumo Corporation announced that it has reached an agreement with Abbott and St. Jude Medical, Inc. to acquire certain products owned by both companies for a total of $1.12 billion."
- [terumo.com](https://www.terumo.com/newsrelease/detail/20170119/260), 2017-01-19: "The acquisition will enhance Terumo's existing product portfolio in the global stent graft market and our vascular graft business will be further strengthened in the US."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.